Part II: The treatment of primary and secondary Raynaud's phenomenon.

Autor: Curtiss P; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Svigos K; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Schwager Z; Department of Dermatology, Lahey Hospital and Medical Center, Burlington, Massachusetts., Lo Sicco K; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York. Electronic address: Kristen.losicco@nyulangone.org., Franks AG Jr; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York; Division of Rheumatology, Department of Internal Medicine, New York University Grossman School of Medicine, New York, New York.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Feb; Vol. 90 (2), pp. 237-248. Date of Electronic Publication: 2022 Jul 06.

Eosinophilic Fasciitis With Concomitant Morphea Profunda Treated With Intravenous Immunoglobulin.

Autor: Gutierrez D; The Ronald O. Perelman Department of Dermatology New York University School of Medicine New York, NY erik.peterson@nyulangone.org., Peterson EL, Kim RH, Franks AG Jr, Lo Sicco KI

Publikováno v: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2021 Dec 01; Vol. 27 (8S), pp. S500-S501.

Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.

Autor: Elkhalifa M; Department of Medicine, Alexandria University, Alexandria, Egypt.; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Orbai AM; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Magder LS; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA., Petri M; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Alarcón GS; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA., Gordon C; Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Merrill J; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Fortin PR; Division of Rheumatology, CHU de Québec - Université Laval, Quebec City, Canada., Bruce IN; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University Hospital NHS Foundation Trust, Manchester Academic Health Science Center, Manchester, UK., Isenberg D; Centre for Rheumatology Research, University College, London, UK., Wallace D; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Nived O; Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Ramsey-Goldman R; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA., Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea., Hanly JG; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Sanchez-Guerrero J; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada., Clarke AE; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Aranow C; Feinstein Institute for Medical Research, Manhasset, NY, USA., Manzi S; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, PA, USA., Urowitz M; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada., Gladman DD; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada., Kalunian K; UCSD School of Medicine, La Jolla, CA, USA., Werth VP; Division of Dermatology, Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center, Philadelphia, PA, USA., Zoma A; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, Scotland, UK., Bernatsky S; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Khamashta M; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, London, UK., Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Buyon JP; Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA., Dooley MA; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA., Vollenhoven RV; Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands.; Free University (VU) Amsterdam, Amsterdam, Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands., Ginzler E; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA., Stoll T; Department of Rheumatology, Kantonsspital, Schaffhausen, Switzerland., Peschken C; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada., Jorizzo JL; Department of Dermatology, Weill Cornell Medicine, New York, NY, USA., Callen JP; Department of Medicine, University of Louisville School of Medicine, Louisville, KY, USA., Lim S; Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, USA., Inanc M; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey., Kamen DL; Division of Rheumatology, Medical University of South Carolina, Charleston, SC, USA., Rahman A; Centre for Rheumatology Research, University College, London, UK., Steinsson K; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland., Franks AG Jr; Division of Rheumatology, Department of Medicine and The Department of Dermatology, New York University School of Medicine, New York, NY, USA.

Publikováno v: Lupus [Lupus] 2021 Jul; Vol. 30 (8), pp. 1283-1288. Date of Electronic Publication: 2021 May 06.

Morphea in a patient undergoing treatment with ustekinumab.

Autor: Steuer AB; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York., Peterson E; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York., Lo Sicco K; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York., Franks AG Jr; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.; Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, New York.

Publikováno v: JAAD case reports [JAAD Case Rep] 2019 Jun 26; Vol. 5 (7), pp. 590-592. Date of Electronic Publication: 2019 Jun 26 (Print Publication: 2019).

Protean Neurologic Manifestations of Two Rare Dermatologic Disorders: Sweet Disease and Localized Craniofacial Scleroderma.

Autor: Wallach AI; NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University School of Medicine, New York, NY, USA. asyawallach@gmail.com., Magro CM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Franks AG Jr; Skin Lupus & Autoimmune Connective Tissue Section, The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.; Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA., Shapiro L; Community Care Rheumatology, Saratoga Springs, NY, USA., Kister I; NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University School of Medicine, New York, NY, USA.

Publikováno v: Current neurology and neuroscience reports [Curr Neurol Neurosci Rep] 2019 Feb 12; Vol. 19 (3), pp. 11. Date of Electronic Publication: 2019 Feb 12.